
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Total revenues | $1.3M-37.0% | $2.1M+19.6% | $1.8M-1.6% | $1.8M+2.7% | $1.7M-5.3% | $1.8M-41.5% | $3.1M |
| Total cost of sales | $949K-27.1% | $1.3M+17.8% | $1.1M+10.9% | $997K-7.2% | $1.1M-8.1% | $1.2M-33.3% | $1.8M |
| Gross profit | $9.8M-0.5% | $9.9M-3.2% | $10.2M-7.8% | $11.1M-4.5% | $11.6M+7.0% | $10.8M-13.2% | $12.5M |
| General and administrative | $13.5M+19.1% | $11.4M-4.4% | $11.9M+8.9% | $10.9M+11.4% | $9.8M-5.0% | $10.3M-0.7% | $10.4M |
| Selling | $2.3M+20.5% | $1.9M-2.6% | $1.9M+6.6% | $1.8M-26.7% | $2.5M-4.7% | $2.6M-3.4% | $2.7M |
| Research and development | $1.2M+21.3% | $962K+14.5% | $840K+14.6% | $733K+35.2% | $542K-29.4% | $767K-47.4% | $1.5M |
| Loss (gain) on sale of assets | $183+101.5% | -$12K+66.4% | -$36K+13.7% | -$42K-299.9% | -$10K+7.8% | -$11K+98.9% | -$1.1M |
| Long-lived asset impairment | $15K | $0 | $0-100.0% | $5K-36.8% | $7K-97.1% | $252K | $0 |
| Goodwill impairment | $1.1M+405.4% | $217K | $0 | $0 | $0-100.0% | $2.9M-22.1% | $3.7M |
| Operating Expenses | $18.1M+25.4% | $14.4M-1.4% | $14.6M+8.9% | $13.4M+4.8% | $12.8M-23.7% | $16.8M | — |
| Loss from operations | -$8.2M-81.8% | -$4.5M-2.7% | -$4.4M-87.9% | -$2.3M-92.7% | -$1.2M+79.5% | -$6.0M-27.9% | -$4.7M |
| Interest and other income (expense) | $152K+665.8% | -$27K+56.0% | -$61K-75.7% | -$35K-46.2% | -$24K-857.9% | -$2K-365.7% | $933 |
| Interest expense | -$150K-66.4% | -$90K-462.6% | -$16K+1.3% | -$16K-14.2% | -$14K+88.7% | -$126K-23.5% | -$102K |
| Gain on the sale of marketable securities | $4K | $0 | — | — | $6K | $0 | — |
| Unrealized gain on marketable securities | $11K | $0 | — | $19K+150.0% | -$37K | — | — |
| Total other expense, net | $16K+113.7% | -$117K-52.0% | -$77K-139.2% | -$32K-100.6% | $5.0M+2296.5% | -$227K-88.0% | -$121K |
| Loss before income taxes | -$8.2M-76.9% | -$4.7M-3.6% | -$4.5M-88.6% | -$2.4M | — | — | — |
| State income tax provision | $21K-8.6% | $23K-30.5% | $32K+98.7% | $16K-16.1% | $19K-35.4% | $30K+98.6% | $15K |
| Consolidated net loss | -$8.2M-76.5% | -$4.7M-3.3% | -$4.5M-88.6% | -$2.4M-164.1% | $3.7M+160.2% | -$6.2M-29.7% | -$4.8M |
| Loss (income) attributable to the noncontrolling interest | $588+100.7% | -$86K-15.4% | -$75K-49.3% | -$50K-11.5% | -$45K-167.5% | $67K-21.9% | $85K |
| Net loss attributable to Tecogen Inc. | -$8.2M-73.3% | -$4.8M-3.5% | -$4.6M-87.8% | -$2.4M-166.2% | $3.7M+160.1% | -$6.2M-30.6% | -$4.7M |
| Net income (loss) per share - basic (in USD per share) | -$0.30-57.9% | -$0.19+0.0% | -$0.19-90.0% | -$0.10-166.7% | $0.15+160.0% | -$0.25 | — |
| Weighted average shares outstanding - basic (in shares) | 27.2M+9.5% | 24.9M+0.0% | 24.9M+0.0% | 24.9M+0.0% | 24.9M+0.0% | 24.9M | — |
| Net income (loss) per share - diluted (in USD per share) | -$0.30-57.9% | -$0.19+0.0% | -$0.19-90.0% | -$0.10-166.7% | $0.15+160.0% | -$0.25 | — |
| Weighted average shares outstanding - diluted (in shares) | 27.2M+9.5% | 24.9M+0.0% | 24.9M+0.0% | 24.9M-1.1% | 25.1M+1.1% | 24.9M | — |
| Products | |||||||
| Services | |||||||
| Energy production | |||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.